KEVEVAPI at a Glance
For many years since its inception, KEVEVAPI has been operating without a strategic plan. This is therefore, the first Strategic Plan for the institute that clearly articulates the shared vision, mission, core functions and strategic objectives to be achieved in the next five years.
In developing this Strategic Plan, we have taken stock of our strengths, weaknesses, opportunities, and threats and have fully appreciated the underlying challenges facing us. We have also taken cognizance of the stakeholders of the Institute and thus embraced the spirit of inclusiveness and consultations in developing this document.
As much as possible, we have mainstreamed our strategic plan with key policy documents such as the Kenya Vision 2030, the First Medium Term Plan, 2008-2012, and the Agricultural Sector Development Strategy (ASDS). This was necessary in order to ensure that KEVEVAPI plays its part in the attainment of Kenya Vision 2030.
The institute aims at re-engineering itself to contribute effectively to national development. This Strategic Plan offers a coherent, ambitious but realizable road map to guide the core business and address the existing and emerging challenges facing the institute. In order to actualize its desired objectives, the institute shall continue to engage all stakeholders in addition to calling upon its entire staff to rededicate themselves to the important task of implementation.
Towards this end, the implementation matrix will become a critical component of the Plan and will form the basis for performance contracting in the institute. All identified activities in the implementation matrix will be translated into the day-to-day assignments of the staff.
In conclusion, the institute welcomes any form of support that would facilitate the smooth implementation of this Strategic Plan. We shall on our part continuously review our operational processes to ensure efficiency and accountability in our undertakings.
KEVEVAPI Legal and institutional framework
The Kenya Veterinary Vaccines Production Institute (KEVEVAPI) was established as a parastatal institution under, Cap 446 of the laws of Kenya on 5th May 1990 through legal Notice No. 223 of 4th June 1990.
This followed the dissolution of a joint venture between the Government of the Republic of Kenya and the Wellcome Trust Foundation of the United Kingdom.
The Institute was created by merging three different institutions that were producing vaccines in Kenya and included the Vaccine Production Laboratory (VPL) at Embakasi, the vaccine production section at the KARI- National Veterinary Research Centre (NVRC) at Muguga, and the vaccine section of Veterinary Research Laboratory at Department of Veterinary Services Headquarter at Kabete.
- Facilities to produce a wide range of vaccines
- Experienced human resource base
- Possession of vaccine master seeds
- Appropriate storage facilities
- Vaccines produced from local isolates
- 30 years experience in vaccine production
- The main producer of inactivated CCPP vaccine worldwide
- Efficiency in production
- Strong distributor network in the region
- Strong linkage with local, regional, and international research organizations
Role of KEVEVAPI in Kenya’s Economy
Most livestock diseases are endemic and pose severe constraints to the livestock industry. They cause economic losses through deaths and decreased production. Some countries like the United States of America and Great Britain have used slaughter and compensation policy in control of Foot and Mouth and New Castle diseases. However, it is a very expensive policy for a developing country like Kenya to undertake.
The only affordable alternative is vaccination; hence the more the need for a functional local veterinary vaccines production facility, thus KEVEVAPI, to provide the appropriate vaccines for the country. The Institute has been in existence as a Centre under Kenya Agricultural Research Institute (KARI) and has been producing vaccines to meet the local demand. This has enhanced the livestock industry to contribute to the GDP.
Contribution of Livestock Sector to National Economy:
The livestock sector contributes about 12% of Kenya’s Gross Domestic Product (GDP), 40% to the agricultural GDP and employs 50% of the agricultural labor force. About 60% of Kenya’s livestock herd is found in the arid and semi-arid lands (ASALs), which constitute about 80% of the country. It is estimated that 10 million Kenyans living in the ASALs derive their livelihood largely from livestock. Livestock plays important roles in Kenya’s socio-economic development and contribute towards household food and nutritional security.
The stakeholders in the sector have recognized the role that a vibrant livestock industry can play to reverse the poverty levels and contribute to the nation’s economic growth.
The recognition is emphasized in various government policy documents such as the ninth National Development Plan – 2002 -2008, Poverty Reduction Strategy Paper (PRSP), Economic Recovery Strategy for Wealth and Employment Creation (ERSWEC) -2003 to 2007, Strategy for Revitalizing Agriculture (SRA) 2004 – 2014, Kenya Vision 2030, Millennium Development Goals (MDGs) and the National Livestock Policy (NLP).
Despite the economic significance, the major challenge is livestock disease outbreaks. For instance, Kenya experienced two major disease outbreaks over the past two years resulting in the imposition of disease-related export restrictions. These had a negative impact on the recovery of trade in livestock and livestock products.
Supportive role in Livestock Production: Kenya possesses one of the best livestock industries in East and Central Africa. However, diseases that exist either in enzootic or epidemic states are the major constraints in livestock production. Nevertheless, these diseases can either be controlled by vaccination or treatment. Vaccination is the most sustainable method of control and covers large proportions of animal herds.
Most common livestock vaccines developed in Kenya and are manufactured by the Institute include the Rinderpest vaccine, Contagious Bovine Pleuropneumonia, and Contagious Caprine Pleuropneumonia. The Institute owns seed stock.
Supportive role in Food Security: KEVEVAPI contributes to the food security and sustainable livelihoods of Kenyans by the provision of vaccines used in the control of major diseases in cattle, small ruminants, and poultry.
Role in Management of Zoonotic Diseases: Rabies and Rift Valley Fever are two important diseases of animals that are transmissible to man. The Institute manufactures both RVF and rabies vaccines.
The wide usage of vaccines against rabies disease has resulted in the dramatic reduction of human cases in Kenya. The Institute’s quick response in the production of the recent RVF vaccine greatly influenced the control of RVF epidemics in both Kenya and Tanzania.
Control of Notifiable and Emerging Disease Outbreaks: An outbreak of any notifiable disease in the country is a great challenge to livestock production, export markets as well as in the cost of sanitary measures taken to contain the disease. To forestall such losses, quantities of veterinary vaccines for strategic use must be readily available for control of notifiable disease outbreaks.
Indeed, the government’s perception expects the Institute to produce adequate reserves of vaccines for strategic use by the Director of Veterinary Services for the public good. The strategic vaccines reserve includes those against Foot and Mouth, Rinderpest, Contagious Bovine Pleuropneumonia, Rabies, Rift Valley Fever, Blue Tongue, LSD, PPR, and New Castle.